J. Mark King

J.
Mark King is primarily engaged by the Firm to work with portfolio company leadership teams in the medical vertical to help them achieve strategic objectives and budgetary goals.
Mr. King will also support buy-side and sell-side processes for new medical device and components opportunities.
Prior to working with Vance Street in 2020, Mr. King held numerous executive leadership roles in the medical device market, both in branded product lines and in contract manufacturing.
Mr. King most recently served as President and Chief Executive Officer of Tegra Medical, a leading medical device contract manufacturer.
Prior to Tegra, Mr. King was President and Chief Executive Officer of Clinical Innovations, a market leader in women’s health medical devices.
In addition to Tegra Medical and Clinical Innovations, Mr. King has held leadership positions at Baxter Healthcare, Cardinal Health and Johnson and Johnson.
Mr. King holds a BS from the School of Technology at Purdue University and has completed Executive Education studies at the University of Wisconsin and Duke University.
Mr. King is a Six Sigma Green Belt.